Divis Laboratories Ltd | DIVI - Sales Revenues

Stock Price
6,429.00
Daily Change
-48.00 -0.74%
Monthly
8.10%
Yearly
5.26%
Q2 Forecast
6,221.55

Divis Laboratories Ltd reported INR26.04B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Alaunos Therapeutics USD 2K 2K Mar/2025
Aurobindo Pharma INR 86.46B 3.6B Dec/2025
Avita Medical AUD 17.61M 805K Dec/2025
Dianthus Therapeutics USD 284K 112K Dec/2025
Divis Laboratories Ltd INR 26.04B 1.11B Dec/2025
Ionis Pharmaceuticals USD 203M 46M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
Lupin INR 71.34B 860M Dec/2025
Moderna USD 678M 342M Dec/2025
Organon & Co USD 1.51B 90M Dec/2025
Revvity USD 772.06M 73.06M Dec/2025
Tectonic Therapeutic USD 0 0 Dec/2024
Tilray USD 217.51M 74.75M Dec/2025
Viatris USD 3.7B 60M Dec/2025
Xeris Pharmaceuticals USD 85.81M 11.43M Dec/2025